At Smilow Cancer Hospital, we understand that quitting smoking is a very difficult habit for many people to give up, but quitting is a very important lifestyle change especially for patients undergoing cancer treatment. It is critical that cancer patients quit smoking after their initial diagnosis, as this has been shown to positively impact their response to treatments, decrease the likelihood that patients will develop second cancers, and increase rates of survival.
The Smoking Cessation Service operates on the principles of Prospect Theory, which states that gain-framed messages that focus on the benefits of quitting smoking may make smokers more likely to quit. All patients are counseled on the benefits of quitting, and supported throughout the process.
The clinicians in the Smoking Cessation Service collaborate with your cancer care team and make every effort to schedule counseling that coincides with preexisting cancer treatment sessions. The program provides tailored treatment based on each patient's individual situation and history with smoking.
The current first-line drug treatments used are FDA-approved nicotine replacement therapies, including the patch, gum, lozenge, inhaler, and nasal spray, bupropion SR (Zyban), and varenicline (Chantix). These, in combination with counseling, have been shown to increase rates of smoking cessation.
To find out more about the service, or to schedule a consultation, please contact the Smoking Cessation Service at 203.688.1378 or via email.